A subcutaneous finger cardioverter-defibrillator system removal under local anesthesia
2014; Elsevier BV; Volume: 179; Linguagem: Inglês
10.1016/j.ijcard.2014.10.053
ISSN1874-1754
AutoresGiuseppe Mario Calvagna, Salvatore Patanè,
Tópico(s)Neurological disorders and treatments
ResumoThe use of implantable cardiac devices has increased in the last 30 years. The evolution of devices in serious cardiac rhythm pathology management has led progressively to the development of devices for the treatment of bradycardia, ventricular arrhythmia, and heart failure and for the prevention of sudden cardiac arrest leading to delivery of pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) plus ICD (CRT-D) [ 1 Calvagna G.M. Patanè S. Severe staphylococcal sepsis in patient with permanent pacemaker. Int. J. Cardiol. Apr 1 2014; 172: e498-e501 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 2 Ward C. Henderson S. Metcalfe N.H. A short history on pacemakers. Int. J. Cardiol. Nov 15 2013; 169: 244-248 Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar , 3 Schulman P.M. Rozner M.A. Sera V. Stecker E.C. Patients with pacemaker or implantable cardioverter-defibrillator. Med. Clin. North Am. Nov 2013; 97: 1051-1075 Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar , 4 Toutouzas K. Synetos A. Tousoulis D. Latsios G. Brili S. Mastrokostopoulos A. Karanasos A. Sideris S. Dilaveris P. Cheong A. Yu C.M. Stefanadis C. Predictors for permanent pacemaker implantation after core valve implantation in patients without preexisting ECG conduction disturbances: the role of a new echocardiographic index. Int. J. Cardiol. Apr 1 2014; 172: 601-603 Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar , 5 Giugno V. Messina F. Crosca S. Treatment failure of low molecular weight heparin bridging therapy after implantation of a permanent pacemaker. Int. J. Cardiol. May 15 2014; 173: e23-e24 Abstract Full Text Full Text PDF PubMed Scopus (17) Google Scholar , 6 Joung Y.H. Development of implantable medical devices: from an engineering perspective. Int. Neurourol. J. 2013 Sep; 17: 98-106 Crossref PubMed Scopus (192) Google Scholar , 7 Aizawa Y. Takatsuki S. Negishi M. Kashimura S. Katsumata Y. Nishiyama T. Kimura T. Nishiyama N. Tanimoto Y. Tanimoto K. Kohsaka S. Sano M. Fukuda K. Clinical characteristics of atrial fibrillation detected by implanted devices and its association with ICD therapy. Int. J. Cardiol. Apr 1 2014; 172: e529-e530 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar , 8 Scarano M. Pezzuoli F. Torrisi G. Calvagna G.M. Patanè S. Cardiovascular implantable electronic devices infective endocarditis. Int. J. Cardiol. May 15 2014; 173: e38-e39 Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar , 9 Ahmed S. Ungprasert P. Srivali N. Ratanapo S. Cheungpasitporn W. Chongnarungsin D. Lead perforation: an uncommon cause of chest pain in a patient with pacemaker. Int. J. Cardiol. Sep 1 2013; 167: e113-4 Abstract Full Text Full Text PDF Scopus (21) Google Scholar , 10 Van Galen K.P. van Dijk J. Regelink J.C. Huijgens P.C. Minnema M.C. Zweegman S. Implantable defibrillators in cardiac amyloidosis. Int. J. Cardiol. May 10 2013; 165: 371-373 Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar , 11 Fang F. Zhang Q. Chan J.Y. Razali O. Azlan H. Chan H.C. Sanderson J.E. Xie J.M. Yu C.M. Early pacing-induced systolic dyssynchrony is a strong predictor of left ventricular adverse remodeling: analysis from the Pacing to Avoid Cardiac Enlargement (PACE) trial. Int. J. Cardiol. Sep 30 2013; 168: 723-728 Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar , 12 Sairaku A. Yoshida Y. Nakano Y. Kihara Y. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation. Int. J. Cardiol. Oct 15 2013; 168: 5273-5276 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 13 Fang F. Chan J.Y. Lee A.P. Sung S.H. Luo X.X. Jiang X. Kwong J.S. Sanderson J.E. Yu C.M. Improved coronary artery blood flow following the correction of systolic dyssynchrony with cardiac resynchronization therapy. Int. J. Cardiol. Sep 1 2013; 167: 2167-2171 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 14 Cheng Z. Deng H. Cheng K. Chen T. Gao P. Fang Q. Implantation of a pacemaker in a patient with persistent left superior vena cava and absence of right superior vena cava. Int. J. Cardiol. Sep 30 2013; 168: e53-e54 Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar , 15 Schukro C. Leitner L. Siebermair J. Pezawas T. Stix G. Kastner J. Schmidinger H. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy. Int. J. Cardiol. Sep 10 2013; 167: 3006-3010 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 16 Gatzoulis K.A. Tsiachris D. Dilaveris P. Archontakis S. Arsenos P. Vouliotis A. Sideris S. Trantalis G. Kartsagoulis E. Kallikazaros I. Stefanadis C. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?. Int. J. Cardiol. Aug 20 2013; 167: 1360-1365 Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar , 17 Peyrol M. Sbragia P. Obadia B. Laine M. Villacampa C. Armero S. Bonello L. Pinto J. Thuny F. Paganelli F. The safety of cardiac resynchronization therapy pacemaker implantation in octogenarians: a monocentric experience. Int. J. Cardiol. Oct 3 2013; 168: 2969-2970 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar , 18 Sankaranarayanan R. Visweswariah R. Fox D.J. New developments in cardiac resynchronization therapy. Br. J. Hosp. Med. (Lond.). 2013 Sep; 74: 503-509 Crossref PubMed Scopus (17) Google Scholar , 19 Patanè S. Paced patient and acute myocardial infarction. Int. J. Cardiol. Nov 1 2012; 161: e16-e17 Abstract Full Text Full Text PDF PubMed Scopus (19) Google Scholar , 20 Veselka J. Krejčí J. Tomašov P. Durdil V. Riedlbauchová L. Honěk J. Honěk T. Zemánek D. Outcome of patients after alcohol septal ablation with permanent pacemaker implanted for periprocedural complete heart block. Int. J. Cardiol. Feb 1 2014; 171: e37-e38 Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar , 21 La Rocca R. Materia V. Falliano M.F. Sciacca N. Marte F. Patanè S. Hyperkalaemic cardiac arrhythmia with pacemaker/implantable cardioverter-defibrillator action disturbance. Int. J. Cardiol. May 3 2012; 156: e49-e50 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar , 22 Udo E.O. van Hemel N.M. Zuithoff N.P. Nijboer H. Taks W. Doevendans P.A. Moons K.G. Long term quality-of-life in patients with bradycardia pacemaker implantation. Int. J. Cardiol. Oct 3 2013; 168: 2159-2163 Abstract Full Text Full Text PDF PubMed Scopus (54) Google Scholar ] and to the recent subcutaneous implantable cardioverter-defibrillator (S-ICD) [ 23 Calvagna G.M. Ceresa F. Patanè S. Subcutaneous implantable cardioverter-defibrillator in a young woman. Int. J. Cardiol. Aug 1 2014; 175: e30-e32 Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar , 24 Reinke F. Löher A. Köbe J. Eckardt L. Current status and problems of the entirely subcutaneous ICD (S-ICD®). Herzschrittmacherther Elektrophysiol. Sep 2013; 24: 165-170 Crossref PubMed Scopus (20) Google Scholar , 25 Aziz S. Leon A.R. El-Chami M.F. The subcutaneous defibrillator—a review of the literature. J. Am. Coll. Cardiol. Apr 22 2014; 63: 1473-1479 Abstract Full Text Full Text PDF PubMed Scopus (65) Google Scholar , 26 Lambiase P.D. Barr C. Theuns D.A. Knops R. Neuzil P. Johansen J.B. Hood M. Pedersen S. Kääb S. Murgatroyd F. Reeve H.L. Carter N. Boersma L. on behalf of the EFFORTLESS Investigators Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur. Heart J. Jul 1 2014; 35: 1657-1665 Crossref PubMed Scopus (348) Google Scholar , 27 Akerström F. Arias M.A. Pachón M. Puchol A. Jiménez-López J. Subcutaneous implantable defibrillator: state-of-the art 2013. World J. Cardiol. Sep 26 2013; 5: 347-354 Crossref PubMed Google Scholar ]. Infectious complications leading also to endocarditis [ 1 Calvagna G.M. Patanè S. Severe staphylococcal sepsis in patient with permanent pacemaker. Int. J. Cardiol. Apr 1 2014; 172: e498-e501 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 8 Scarano M. Pezzuoli F. Torrisi G. Calvagna G.M. Patanè S. Cardiovascular implantable electronic devices infective endocarditis. Int. J. Cardiol. May 15 2014; 173: e38-e39 Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar , 28 Calvagna G.M. Recall, malfunzionamenti e infezioni in portatori di PM/ICD.Possono condizionare le scelte clinico-interventistiche e la qualità della vita?. GIAC. 2010; 13: 217-222 Google Scholar , 29 Scarano M. Pezzuoli F. Patanè S. Brucella infective endocarditis. Int. J. Cardiol. Apr 1 2014; 172: e509-e510 Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar , 30 Patanè S. Is there a need for bacterial endocarditis prophylaxis in patients undergoing urological procedures?. J. Cardiovasc. Transl. Res. Apr 2014; 7: 369-371 Crossref PubMed Scopus (41) Google Scholar , 31 Patanè S. Is there a need for bacterial endocarditis prophylaxis in patients undergoing gastrointestinal endoscopy?. J. Cardiovasc. Transl. Res. Apr 2014; 7: 372-374 Crossref PubMed Scopus (39) Google Scholar , 32 Calvagna G.M. Progressivo malfunzionamento di elettrocatetere da stimolazione cardiaca permanente secondario a processo infettivo asintomatico. GIAC. 2012; 15: 51-54 Google Scholar , 33 Calvagna G.M. Curatolo S. La Greca S. Evola R. Sepsi Stafilococciche in pazienti portatori di PM e\o ICD: Dal trattamento antibiotico all'intervento di Rimozione Transvenosa Manuale. G. Ital. Arit. Cardiostim. Marzo. 2010; 13 Google Scholar , 34 Patanè S. A dark side of the cardio-oncology: the bacterial endocarditis prophylaxis. Int. J. Cardiol. Jun 14 2012; 157: 448-449 Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar , 35 Calvagna G.M. Mangano A. Evola R. Infezioni su estremita' distali degli elettrocateteri da stimolazione cardiaca permanente rimossi mediante tecnica transvenosa manuale: casistica dal 2002 al 2007 presso centro unico dedicato. G. Ital. Aritm. Cardiostim. 2008; 4: 65-68 Google Scholar ] and non-infectious complications [ 9 Ahmed S. Ungprasert P. Srivali N. Ratanapo S. Cheungpasitporn W. Chongnarungsin D. Lead perforation: an uncommon cause of chest pain in a patient with pacemaker. Int. J. Cardiol. Sep 1 2013; 167: e113-4 Abstract Full Text Full Text PDF Scopus (21) Google Scholar , 21 La Rocca R. Materia V. Falliano M.F. Sciacca N. Marte F. Patanè S. Hyperkalaemic cardiac arrhythmia with pacemaker/implantable cardioverter-defibrillator action disturbance. Int. J. Cardiol. May 3 2012; 156: e49-e50 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar , 23 Calvagna G.M. Ceresa F. Patanè S. Subcutaneous implantable cardioverter-defibrillator in a young woman. Int. J. Cardiol. Aug 1 2014; 175: e30-e32 Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar , 36 Imazio M. Hoit B.D. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int. J. Cardiol. Sep 30 2013; 168: 648-652 Abstract Full Text Full Text PDF PubMed Scopus (142) Google Scholar , 37 Chikata A. Omi W. Saeki T. Nagai H. Sakagami S. Repeated pacemaker dysfunction in a patient with recurrent takotsubo cardiomyopathy precipitated by hyponatremia. Int. J. Cardiol. Jan 1 2014; 170: 443-444 Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar , 38 Kawata H. Patel J. McGarry T. Joshi R. Krummen D. Feld G. Birgersdotter-Green U. Obese female patients have higher rates of lead dislodgement after ICD or CRT-D implantation. Int. J. Cardiol. Apr 1 2014; 172: e522-e524 Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar , 39 Calvagna G.M. Evola R. Complicanze non infettive o malfunzionamenti in pazienti portatori di PM e/o ICD: importanza della rimozione transvenosa. G. Ital. Aritm. Cardiostim. 2009; 12: 69-78 Google Scholar ] often necessitating removal [ 1 Calvagna G.M. Patanè S. Severe staphylococcal sepsis in patient with permanent pacemaker. Int. J. Cardiol. Apr 1 2014; 172: e498-e501 Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar , 2 Ward C. Henderson S. Metcalfe N.H. A short history on pacemakers. Int. J. Cardiol. Nov 15 2013; 169: 244-248 Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar , 8 Scarano M. Pezzuoli F. Torrisi G. Calvagna G.M. Patanè S. Cardiovascular implantable electronic devices infective endocarditis. Int. J. Cardiol. May 15 2014; 173: e38-e39 Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar , 39 Calvagna G.M. Evola R. Complicanze non infettive o malfunzionamenti in pazienti portatori di PM e/o ICD: importanza della rimozione transvenosa. G. Ital. Aritm. Cardiostim. 2009; 12: 69-78 Google Scholar , 40 Calvagna G.M. Patanè S. Romeo P. Ceresa F. Sansone F. Patanè F. Embolization and retrieval of an anchoring sleeve during transvenous lead extraction. Int. J. Cardiol. May 15 2014; 173: e42-e44 Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar , 41 Calvagna G.M. Foti R. Lisi M. Evola R. Rimozione transvenosa manuale di elettrocateteri da Pacemaker e\o ICD malfunzionanti o infetti mediante tecnica transvenosa manuale: Esperienza di unico centro regionale dedicato (anni 2002–2007). G. Ital. Aritm. Cadiostim. 2007; 4: 30-35 Google Scholar , 42 Calvagna G.M. Evola R. Scardace G. Valsecchi S. Single-operator experience with a mechanical approach for removal of pacing and implantable defibrillator leads. Europace. Nov 2009; 11: 1505-1509 Crossref PubMed Scopus (42) Google Scholar , 43 Calvagna G.M. Evola R. Scardace G. Valsecchi S. Successful removal of a jugular implantable defibrillator lead with mechanical single-sheath technique. Pacing Clin. Electrophysiol. Sep 2012; 35: e258-e260 Crossref PubMed Scopus (21) Google Scholar , 44 Calvagna G.M. Evola R. Valsecchi S. A complication of pacemaker lead extraction: pulmonary embolization of an electrode fragment. Europace. 2010; 12: 613 Crossref PubMed Scopus (23) Google Scholar , 45 Calvagna G.M. Romeo P. Ceresa F. Valsecchi S. Transvenous retrieval of foreign objects lost during cardiac device implantation or revision: a 10-year experience. Pacing Clin. Electrophysiol. 2013 Jul; 36: 892-897 Crossref PubMed Scopus (27) Google Scholar ] affect patient wellbeing also leading to psychological difficulty increase [ 46 Pedersen S.S. Hoogwegt M.T. Jordaens L. Theuns D.A. Procedure- and device-related complications and psychological morbidity in implantable cardioverter defibrillator patients. Int. J. Cardiol. Sep 20 2013; 168: 606-607 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar , 47 Feola M. Vallauri P. Salvatico L. Vado A. Testa M. Neuropsychological impact of implantable cardioverter defibrillator in congestive heart failure patients. Int. J. Cardiol. Jun 5 2013; 166: 275-276 Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar , 48 Denollet J. Tekle F.B. Pedersen S.S. van der Voort P.H. Alings M. van den Broek K.C. Prognostic importance of distressed (type D) personality and shocks in patients with an implantable cardioverter defibrillator. Int. J. Cardiol. Sep 10 2013; 167: 2705-2709 Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar , 49 Pedersen S.S. Hoogwegt M.T. Jordaens L. Theuns D.A. Pre implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12 months post implantation. Int. J. Cardiol. Jun 5 2013; 166: 215-220 Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar , 50 Ingles J. Sarina T. Kasparian N. Semsarian C. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. Int. J. Cardiol. Oct 9 2013; 168: 3779-3784 Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar , 51 van den Broek K.C. Tekle F.B. Habibović M. Alings M. van der Voort P.H. Denollet J. Emotional distress, positive affect, and mortality in patients with an implantable cardioverter defibrillator. Int. J. Cardiol. May 10 2013; 165: 327-332 Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar , 52 Calvagna G.M. Torrisi G. Giuffrida C. Patanè S. Pacemaker, implantable cardioverter defibrillator, CRT, CRT-D, psychological difficulties and quality of life. Int. J. Cardiol. Jun 15 2014; 174: 378-380 Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar ] in the emerging scenario of concomitant problems and diseases [ 53 Pugliatti P. Donato R. Di Bella G. Carerj S. Patanè S. Contrast-enhancing right atrial thrombus in cancer patient. Int. J. Cardiol. May 15 2014; 173: e35-e37 Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar , 54 Pugliatti P. Donato R. Zito C. Carerj S. Patanè S. Cardio inhibitory vasovagal syncope in a cancer patient. Int. J. Cardiol. Jun 15 2014; 174: e64-e65 Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar , 55 Patanè S. Cardiotoxicity: cisplatin and long term cancer survivors. Int. J. Cardiol. Jul 15 2014; 175: 201-202 Abstract Full Text Full Text PDF PubMed Scopus (68) Google Scholar , 56 Patanè S. A challenge in cardiology: the oncosurgery. Int. J. Cardiol. Jun 15 2014; 174: 411-412 Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar , 57 Patanè S. Heart failure and breast cancer: emerging controversies regarding some cardioprotective strategies. J. Card. Fail. Jun 2014; 20: 456-457 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 58 Patanè S. Insights into cardio-oncology: adrenergic receptor signaling and pathways in breast cancer. Curr. Med. Res. Opin. Jun 26 2014; : 1-2 Crossref PubMed Scopus (1) Google Scholar , 59 Patanè S. Breast cancer treatment cardioprotective strategies: the King is naked. J. Am. Heart Assoc. 2014; (Published July 22,2014 http://www.jaha.ahajournals.org/content/3/2/e000665/reply) Google Scholar , 60 Patanè S. ERBB1/EGFR and ERBB2 (HER2/neu)—targeted therapies in cancer and cardiovascular system with cardiovascular drugs. Int. J. Cardiol. Oct 20 2014; 176: 1301-1303 Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar , 61 Patanè S. Cancer multidrug resistance—targeted therapy in both cancer and cardiovascular system with cardiovascular drugs. Int. J. Cardiol. Oct 20 2014; 176: 1306-1308 Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar , 62 Patanè S. HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs. Int. J. Cardiol. Oct 20 2014; 176: 1082-1085 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 63 Patanè S. Ebola: is there a hope from treatment with cardiovascular drugs?. Int. J. Cardiol. Dec 15 2014; 177: 524-526 Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar , 64 Patanè S. Cardiotoxicity: anthracyclines and long term cancer survivors. Int. J. Cardiol. Oct 20 2014; 176: 1326-1328 Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar , 65 Patanè S. Cardiotoxicity: Trastuzumab and cancer survivors. Int. J. Cardiol. Dec 15 2014; 177: 554-556 Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar , 66 Patanè S. The emerging scenario of the onco-cardiovascular patients. J. Cardiol. Ther. 2014; 1: 141-149 Google Scholar , 67 Patanè S. M3 muscarinic acetylcholine receptor in cardiology and oncology. Int. J. Cardiol. Dec 15 2014; 177: 646-649 Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar , 68 Pugliatti P. Recupero A. Zito C. Patanè S. The chance finding of an atrial septal defect in a cancer patient. Int. J. Cardiol. Dec 15 2014; 177: e68-e69 Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar , 69 La Rocca R. Ferrari-Toninelli G. Patanè S. Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure. Int. J. Cardiol. 2014; 177: 57-60 Abstract Full Text Full Text PDF PubMed Scopus (19) Google Scholar , 70 Calvagna G.M. Ceresa F. Patanè S. Pocket infection as a complication of a subcutaneous implantable cardioverter-defibrillator. Int. J. Cardiol. Dec 15 2014; 177: 616-618 Abstract Full Text Full Text PDF Scopus (21) Google Scholar , 71 Ceresa F. Calvagna G.M. Patanè S. Di Maggio E.M. Romeo P. Patanè F. Cardiac perforation of the right ventricle: A rare complication of pacemaker implantation. The importance of a collaborative vision of a multi-disciplinary treatment team. Int. J. Cardiol. Dec 15 2014; 177: 621-624 Abstract Full Text Full Text PDF PubMed Scopus (14) Google Scholar , 72 Calvagna G.M. Patanè S. Intravascular recovery of electrode fragments as a possible complication of transvenous removal intervention. Int. J. Cardiol. Dec 15 2014; 177: 560-563 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar , 73 Patanè S. Is there a role for quinazoline-based α(1)-adrenoceptor antagonists in cardio-oncology?. Card Drugs Ther. Sep 18 2014; https://doi.org/10.1007/s10557-014-6552-7 Crossref Scopus (26) Google Scholar , 74 Calvagna G.M. Costanzo L. Di Pino A. Patanè S. Leads extraction in a young girl with dehiscence of a pacemaker implanted in the subpectoral region. Int. J. Cardiol. Oct 20 2014; 176: e135-e136 Abstract Full Text Full Text PDF PubMed Scopus (17) Google Scholar , 75 Romeo P. Calvagna G.M. Giunta M. Vitale F.V. Patanè S. Removal of an intracardiac lost port-A catheter utilizing a simple low-cost method. Int. J. Cardiol. Oct 20 2014; 176: 1309-1311 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar , 76 Patanè S. Regulator of G-protein signaling 2 (RGS2) in cardiology and oncology. Int. J. Cardiol. Oct 22 2014; https://doi.org/10.1016/j.ijcard.2014.10.088 Abstract Full Text Full Text PDF Scopus (13) Google Scholar ]. The modern ICDs in the market deliver a maximum energy of 35 to 41 J in relation to the model using single-coil leads or dual-coil leads. In particular patients, the electric shock delivered, cannot be sufficiently effective to suppress life-threatening ventricular arrhythmias associated with serious diseases of the myocardium dilated cardiomyopathy (CMD) with non-compacted myocardium. In such patients, in addition to the ICD, devices may be used that facilitate cardioversion such as epicardial cardioverter defibrillation patches (Fig. 1) or a subcutaneous single-finger cardioverter-defibrillator (ICD) system (Fig. 2) [ 77 Osswald B.R. De Simone R. Most S. Tochtermann U. Tanzeem A. Karck M. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?. Eur. J. Cardiothorac. Surg. Mar 2009; 35: 489-492 Crossref PubMed Scopus (18) Google Scholar , 78 Hilgendorf I. Biermann J. Faber T. Bode C. Asbach S. Shock lead impedance alert: replace or reconsider?. Circ. Arrhythm Electrophysiol. Jun 2011; 4: e15-e17 Crossref Scopus (2) Google Scholar , 79 Kettering K. Mewis C. Dörnberger V. Vonthein R. Bosch R.F. Seipel L. Kühlkamp V. Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads. Pacing Clin. Electrophysiol. Oct 2004; 27: 1355-1361 Crossref PubMed Scopus (40) Google Scholar , 80 Luedemann M. Hund K. Stertmann W. Michel-Behnke I. Gonzales M. Akintuerk H. Schranz D. Implantable cardioverter defibrillator in a child using a single subcutaneous array lead and an abdominal active can. Pacing Clin. Electrophysiol. Jan 2004; 27: 117-119 Crossref PubMed Scopus (31) Google Scholar , 81 Madan N. Gaynor J.W. Tanel R. Cohen M. Nicholson S. Vetter V. Rhodes L. Single-finger subcutaneous defibrillation lead and "active can": a novel minimally invasive defibrillation configuration for implantable cardioverter-defibrillator implantation in a young child. J. Thorac. Cardiovasc. Surg. Nov 2003; 126: 1657-1659 Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar , 82 Gradaus R. Block M. Seidl K. Brunn J. Isgro F. Hammel D. Hauer B. Breithardt G. Bocker D. Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II. J. Cardiovasc. Electrophysiol. Aug 2001; 12: 921-927 Crossref PubMed Scopus (35) Google Scholar , 83 Kühlkamp V. Dörnberger V. Khalighi K. Mewis C. Suchalla R. Ziemer G. Seipel L. Effect of a single element subcutaneous array electrode added to a transvenous electrode configuration on the defibrillation field and the defibrillation threshold. Pacing Clin. Electrophysiol. Dec 1998; 21: 2596-2605 Crossref PubMed Scopus (30) Google Scholar ]. Epicardial patches are placed at the sides of the heart through a cardiac surgery approach under general anesthesia, while subcutaneous single-finger cardioverter-defibrillator (ICD) system is placed through subcutaneous tunneling technique in general or local anesthesia by an interventional cardiologist. We describe the case of the removal under local anesthesia and re-implantation of a subcutaneous single-finger cardioverter-defibrillator (ICD) system in a 36-year-old Italian man with CMD and with non-compacted myocardium and severe aortic, mitral and tricuspidal regurgitation. The patient had received an ICD PM with atrial lead, ventricular lead and Finger lead (Fig. 1 panel A) in the left pre-pectoral area awaiting cardiac transplantation. We observed a severe pocket sepsis with lead malfunctioning due to Finger lead dislodgement presenting in the left thoraco-axillary region (Fig. 1 panel B) and we removed the complete system. For the transvenous endocardiac lead removal, the venous entry-site approach was left subclavian vein and Byrd sheath (CooK Vascular Inc.) were utilized (Fig. 1 panels C and D). For the subcutaneous Finger lead removal, C Sheath Liberator (CooK Vascular Inc.) was utilized. Both procedures were performed under local anesthesia with subcutaneous injection with lidocaine 2%. After a 24 day antibiotic treatment, a new ICD was implanted in the down left subpectoral region with dual coil defibrillation lead through subclavian right vein access and connected to the device through subcutaneous suprasternal tunneling technique from right to left region (Fig. 2). The electric shock delivered weren't sufficiently effective to suppress induced ventricular tachycardia and thus we proceeded with lead Finger positioning through subcutaneous tunneling technique from device to left paravertebral region. The two 35 J ICD electric shocks delivered weren't sufficiently effective to suppress induced ventricular tachycardia and the second external electric shock delivered with bipolar 200 J. Epicardial patches were placed at the sides of the heart through a cardiac surgery approach under general anesthesia. Fig. 2Panels A and B transvenous endocardiac lead removal. The venous entry-site approach was left subclavian vein and Byrd sheath (CooK Vascular Inc.) were utilized. Panel C: A new ICD was implanted in the down left subpectoral region with dual coil defibrillation lead through subclavian right vein access and connected to the device through subcutaneous suprasternal tunneling technique from right to left region. Thus we proceeded with lead Finger positioning through subcutaneous tunneling technique from device to left paravertebral region. View Large Image Figure Viewer Download Hi-res image
Referência(s)